tradingkey.logo

Valneva Receives First Marketing Authorization For Ixchiq® In Brazil

ReutersApr 14, 2025 3:51 PM

- Valneva SE VLS.PA:

  • VALNEVA SAYS BRAZILIAN HEALTH REGULATORY AGENCY (ANVISA) HAS GRANTED MARKETING AUTHORIZATION TO ITS SINGLE-DOSE VACCINE IXCHIQ

  • VALNEVA RECEIVES FIRST MARKETING AUTHORIZATION FOR IXCHIQ® IN A CHIKUNGUNYA ENDEMIC COUNTRY

  • APPROVAL ENABLES INITIATION OF LARGE-SCALE CLINICAL TRIALS OF IXCHIQ® IN BRAZIL, INCLUDING COMMITTED PHASE 4 CLINICAL TRIALS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI